Back to Journals » Integrated Blood Pressure Control » Volume 13

Matrix Metalloproteinases and Hypertension-Mediated Organ Damage: Current Insights

Authors Bisogni V, Cerasari A, Pucci G, Vaudo G

Received 22 July 2020

Accepted for publication 12 September 2020

Published 2 November 2020 Volume 2020:13 Pages 157—169


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Turgay Celik

Valeria Bisogni,1,* Alberto Cerasari,1,2,* Giacomo Pucci,1,2 Gaetano Vaudo1,2

1Unit of Internal Medicine, Terni University Hospital, Terni, Italy; 2Department of Medicine, University of Perugia, Perugia, Italy

*These authors contributed equally to this work

Correspondence: Valeria Bisogni
Unit of Internal Medicine, Terni University Hospital, Via Tristano di Joannuccio, 1, Terni, TR 05100, Italy
Tel +39 0744 205328

Abstract: Matrix metalloproteinases (MMPs) are important extracellular enzymes involved in many physiological and pathological processes. Changes in the activity and concentration of specific MMPs, as well as the unbalance with their inhibitors (tissue inhibitors of metalloproteinases – TIMPs), have been described as a part of the pathogenic cascade promoted by arterial hypertension. MMPs are able to degrade various protein substrates in the extracellular matrix, to influence endothelial cells function, vascular smooth muscle cells migration, proliferation and contraction, and to stimulate cardiomyocytes changes. All these processes can be activated by chronically elevated blood pressure values. Animal and human studies demonstrated the key function of MMPs in the pathogenesis of hypertension-mediated vascular, cardiac, and renal damage, besides age and blood pressure values. Thus, the role of MMPs as biomarkers of hypertension-mediated organ damage and potential pharmacological treatment targets to prevent further cardiovascular and renal complications in hypertensive population is increasingly supported. In this review, we aimed to describe the main scientific evidence about the behavior of MMPs in the development of vascular, cardiac, and renal damage in hypertensive patients.

Keywords: matrix metalloproteinases, arterial hypertension, hypertension-mediated organ damage

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]